Simplify Logo

Full-Time

Associate Director

Digital Centric Marketing

Posted on 2/27/2024

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for central nervous system conditions

Hardware
Biotechnology

Senior

New York, NY, USA

Category
Medical, Clinical & Veterinary
Required Skills
Sales
Management
Marketing
Data Analysis
Requirements
  • BA or BS; MBA or other advanced degree preferred
  • Minimum 5-7 years of experience in pharmaceutical/biotechnology marketing
  • Strong digital marketing aptitude and experience
  • Ability to work on site Monday, Tuesday, and Thursday
  • Experience in Generative AI / Business AI
  • CNS disease experience and/or launch experience
  • Proven ability to run multiple tasks concurrently under aggressive timelines in a dynamic environment, comfortable with uncertainty and high expectations
  • Strong project and process management skills, including competency in agency management and budget management
  • Strong interpersonal and presentation skills
Responsibilities
  • Drive the development and implementation of integrated, multi-channel Healthcare Professional (HCP) campaign strategies and tactics
  • Implement non-personal, omnichannel strategies to engage healthcare professionals and optimize campaign effectiveness using AI-driven insights
  • Lead the development and implementation of digital field tools and resources designed to extend reach, frequency, and impact to HCPs
  • Identify appropriate measurements and ROI, and develop comprehensive reporting to evaluate the effectiveness of marketing campaigns
  • Lead reviews of promotional materials with Regulatory/Legal/Medical
  • Collaborate effectively with sales and marketing, market access, patient support, market research, medical affairs, commercial operations, data and analytics, finance, and other cross-functional partners
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

With a dedicated focus on developing therapies for central nervous system conditions—such as depression, Alzheimer’s disease agitation, and fibromyalgia—this company stands out by addressing critical unmet medical needs with promising products like AXS-05 and AXS-07. The firm fosters a culture deeply committed to innovation and the development of therapies with novel mechanisms of action, showcasing strong potential in the medical field and enhancing patient care in areas with limited treatment options.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

110%

1 year growth

110%

2 year growth

110%
INACTIVE